Researchers Found The Effect Of Fatty Acids – Part 2 of 3
One key question: Do dietary fatty acids have the adeptness to cross the brain’s protective blood-brain barrier? This natural barrier shields the brain from harmful chemicals found elsewhere in the body, the researchers said. The descendant is particularly important for Alzheimer’s disease research, because prior studies have shown that Alzheimer’s patients have lower levels of a key omega-3 fatty acid in the cerebrospinal fluid (the bright that surrounds the central nervous system). In the six-month study, 18 patients with mild Alzheimer’s disease got a daily omega-3 supplement while 15 patients received a placebo, or imitation pill.
According to Freund-Levi’s group, patients who got the supplement showed higher levels of two major forms of omega-3 fatty acids in their cerebrospinal fluid – docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). The placebo assemble displayed no such change. Concentrations of DHA in cerebrospinal fluid were directly linked to the degree of change in Alzheimer’s disease symptoms and in markers of infection in the fluid.